Antineoplastic drugs in sewage from hospitals and households;Les médicaments anticancéreux dans les effluents hospitaliers et domestiques

Environnement, Risques et Sante

Volumn 5, Issue 4, 2006, Pages 266-270

  Castegnaro, Marcel ^a   Hansel, Sylvie ^b  

^a Les Collanges ^*  (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

Antineoplastic drugs; Drug residues; Medical waste; Risk; Sewage; Toxic actions; Water

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; AZATHIOPRINE; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CHLOROZOTOCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; DRUG RESIDUE; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MELPHALAN; METHYLTHIOURACIL; MITOMYCIN C; MITOXANTRONE; OXALIPLATIN; PROCARBAZINE; SARCOLYSIN; SEMUSTINE; TAMOXIFEN; TENIPOSIDE; THIOTEPA; THIOURACIL;

CONFERENCE PAPER; DOMESTIC WASTE; HOSPITAL WASTE; SEWAGE DISPOSAL; SEWAGE EFFLUENT; SEWAGE TREATMENT PLANT; WASTE DISPOSAL;

EID: 33747485490     PISSN: 16350421     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Coleman MP, Estève J, Damiecki P, Arslan D, Renard H. Trends in Cancer incidence and mortality. Publication du CIRC, n° 121. Lyon: Centre international de recherche sur le cancer (CIRC), 1983.
2. Ferlay J, Bray F, Pisani P, Parkin M. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. Lyon: Centre international de recherche sur le cancer (CIRC), 2001 (cédérom).
3. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans, overall evaluations of the carcinogenicity: An updating of IARC Monographs volumes 1-42. Lyon: IARC, 1987 (et mises à jour suivantes).
4. Centre national hospitalier d'information sur le médicament (CNIHM). Médicaments utilisés en cancérologie. Dossier du CNIHM 2001; XXII: 1-2.
5. Emms SC. Anal sac tumours of the dog and their response to cytoreductive surgery and chemotherapy. Aust Vet J 2005; 83: 340-3.
6. Kosarek CE, Kisseberth WC, Gallant SL, Couto CG. Clinical evaluation of gemcitabine in dogs with spontaneously occurring malignancies. J Vet Intern Med 2005; 19: 81-6.
7. Langova V, Mutsaers AJ, Phillips B, Straw R. Treatment of eight dogs with nasal tumours with alternating doses of doxorubicin and carboplatin in conjuncion with oral piroxicam. Aust Vet J 2004; 82: 676-80.
8. Benoit P. Étude et prévention des risques liés à la manipulation des cytostatiques en médecine vétérinaire. Enquête auprès de 134 praticiens. Thèse soutenue à l'université Claude Bernard de Médecine et Pharmacie le 28 juin 2005.
9. Steger-Hartmann T, Kümmerer K, Schecker J. Trace analysis of the antineoplastics IF and cyclophosphamide in sewage water by two step solid phase extraction and GC/MS. J Chromatogr A 1996; 726: 179-84.
10. Steger-Hartmann T, Kümmerer K, Hartmann A. Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicol Environ Saf 1997; 36: 174-9.
11. Kümmerer K, Steger-Hartmann T, Meyer M. Biodegradability of the anti-tumor agent ifosfamide and its occurrence in hospital effluents and communal sewage. Water Res 1997; 31: 2705-10.
12. Kummerer K, Helmers E, Hubner P, et al. European hospitals as a source for platinum in the environment in comparison with other sources. Sci Total Environ 1999; 225: 155-65.
13. Aherne GW, Hardcastle A, Nield AH. Cytotoxic drugs and the aquatic environment: estimation of bleomycin in river and water samples. J Pharm Pharmacol 1990; 42: 741-2.
14. Aherne GW, English J, Marks V. The role of immunoassay in the analysis of microcontaminants in river samples. Ecotoxicol Environ Saf 1985; 9: 79-83.
15. Ternes TA. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998; 32: 3245-60.
16. Zuccato E, Castiglioni A, Fanelli R. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J Hazard Mater 2005; 122: 205-9.
17. Kümmerer K, Steger-Hartmann T, Baranyai A, Biirhaus I. Evaluation of the biological degradation of the antineoplastics cyclophosphamide and ifosfamide with the Closed Bottle Test (OECD 301 D). Zbl Hyg 1996; 198: 215-25.
18. Kümmerer K, Al-Ahmad A, Steger-Hartmann T. Verhalten des Zytostatikums Epirubicin hydrochlorid in der aquatischen Umwelterste Ergebnisse. Umweltmed Forsch Prax 1996; 1: 133-7.
19. Kümmerer K, Al-Ahmad A. Biodegradability of the anti-tumour agents 5-fluorouracil, cytarabine and gemcitabine: impact of the chemical structure and synergistic toxicity with hospital effluents. Acta Hydrochim Hydrobiol 1997; 25: 166-72.
20. er février 2001 établissant les règles particulières de prévention des risques cancérogènes, mutagènes ou toxiques pour la reproduction et modifiant le code du travail (deuxième partie: décrets en Conseil d'État). Journal officiel de la République française, 3 février 2001: 1866-68.